Glycemic and lipid control in patients with diabetes at time of myocardial infarction.
Fiche publication
Date publication
avril 2024
Journal
Annales pharmaceutiques francaises
Auteurs
Membres identifiés du Cancéropôle Est :
Pr COTTIN Yves
Tous les auteurs :
Lacqua C, Adam H, Zeller M, Vadot L, Bichat F, Maza M, Cottin Y, Boulin M
Lien Pubmed
Résumé
Cardiovascular risk is increased in patients with diabetes. Little is known about glycemic and lipid control in patients with diabetes. We aimed to assess glycemic and lipid controls in patients with diabetes at time of their myocardial infarction.
Mots clés
diabetes, glycemic control, lipid control, myocardial infarction, pharmacotherapy
Référence
Ann Pharm Fr. 2024 04 27;: